Company Filing History:
Years Active: 2020-2025
Title: Michael Bethune: Innovator in Peptide-MHC Compacts
Introduction
Michael Bethune is a notable inventor based in Castro Valley, CA (US). He has made significant contributions to the field of immunology through his innovative work on peptide-MHC molecules. With a total of 2 patents, his research focuses on advancing methods for capturing cancer neoepitope-reactive T cells.
Latest Patents
Bethune's latest patents include the development of antigenic peptide-MHC molecules, referred to as comPACTs. These patents disclose methods for producing such molecules, as well as techniques for creating libraries of comPACT polynucleotides and polypeptides. The exemplary use of these innovations lies in their potential to capture cancer neoepitope-reactive T cells, which could lead to breakthroughs in cancer treatment.
Career Highlights
Throughout his career, Michael Bethune has worked with various companies, including Adoc Ssf, LLC and Pact Pharma, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of his notable coworkers include Olivier Dalmas and Zheng Pan. Their collaborative efforts have contributed to the advancement of research in peptide-MHC compacts and related technologies.
Conclusion
Michael Bethune's work in the field of peptide-MHC compacts showcases his dedication to innovation and research in immunology. His contributions have the potential to significantly impact cancer treatment methodologies.